In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis-Reference-Cited by-同舟云学术

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis

Published:2021-07 Issue: Volume:203 Page:82-84
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Mumoli Nicola,Conte Giulia,Cei Marco,Vitale Josè,Capra Riccardo,Rotiroti Giuseppe,Porta Cesare,Monolo Davide,Colombo Alessandra,Mazzone Antonino,Kucher Nils,Konstantinides Stavros V.,Dentali Francesco,Barco Stefano

Publisher

Elsevier BV

Subject

Hematology

Reference13 articles.

1. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;Lodigiani;Thromb. Res.,2020

2. Incidence of acute pulmonary embolism in COVID-19 patients: systematic review and meta-analysis;Roncon;Eur. J. Intern. Med.,2020

3. Pulmonary embolism in patients with COVID-19 pneumonia;Bompard;Eur. Respir. J.,2020

4. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial;Barco;Trials,2020

5. Anticoagulant interventions in hospitalized patients with COVID-19: a scoping review of randomized controlled trials and call for international collaboration;Tritschler;J. Thromb. Haemost.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PECULIARITIES OF THE COURSE OF PULMONARY EMBOLISM DURING THE COVID-19 PANDEMIC;Wiadomości Lekarskie;2023

2. Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis;Journal of Hematology;2022-10

3. Venous thromboembolism in COVID-19;Saudi Medical Journal;2022-09

4. Empiric Anticoagulation Therapy in Hospitalized COVID-19 Patients: An Evaluation of Bleeding Risk Scores Performances in Predicting Bleeding Events;Journal of Clinical Medicine;2022-08-24

5. Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial;The Lancet Haematology;2022-08